OmegaGenesis is a bio-technology company developing nano-materials for human
body management to effectively treat conditions where the growth or anti-growth
of blood cells determines the outcome.
Human body management applications where blood vessels greatly determine the
outcome range from cancer and malignancies treatments to common wound healing
and skin reactivation.
OmegaGenesis was founded to discover and produce suitable nano-materials to
manage human body functions at nano scale - the cell and sub-cell level
-- accelerating cellular-based biologic therapies. These nano-materials will
enable Doctors to treat disease at sub-cell level in a less intrusive manner
instead of treating the disease at the organ or tissue level.